Skip to content
DraconiticResearch
Search Sources API
206,698 studies31 sourcesUpdated 34 min ago

Oncology

5,185 studies511 in 7 days2,486 in 30 days

Filters
Type
Date
Clear

Latest

5,185 studies

  1. The PD-L1-mTOR intersection in tumor migration and invasion.
    Rafael Palavro, Thales Thor Ramos Previato, Douglas Bottega Pazzin +5
    Molecular biology reportsPeer-reviewedCC BYFull textOncologyEurope PMC
  2. Prognostic Role of the C-PLAN Index in Metastatic Melanoma: A Two-Center Retrospective Study
    İrfan Buğday, Safiye Selcen Vicdanlı, Mevlüde İnanç +2
    Journal of Clinical MedicinePeer-reviewedCC BY 4.0OncologyCrossref
  3. Co-Occurrence Patterns of Pathological High-Risk Factors and Predictive Value of PET Metabolic Features in Lung Adenocarcinoma: A Retrospective Cohort Study of 1292 Cases
    Qiuyu Leng, Yu Huang, Bowen Zhao +3
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  4. Digital Health Supportive Care Interventions for Breast Cancer Survivors: An Umbrella Review of Systematic Reviews and Meta-Analyses
    Mattias Wei Ren Kon, Joan Ern Xin Tan, Charmaine Su Min Tan +5
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  5. Clinical Profile and Survival of Oropharyngeal Squamous-Cell Carcinoma in a Region of Northern Spain with a Low HPV-Attributable Fraction: A Retrospective Cohort Study
    Carlos M. Chiesa-Estomba, Maider Andueza-Guembre, Paulina Droppelman-Álvarez +6
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  6. Immune and Circulating Biomarkers in Hepatocellular Carcinoma: Prognostic and Predictive Relevance for Immunotherapy
    Fady Sidhom, Emin Karabiber, Rafik ElBeblawy +4
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  7. Immunophenotyping of Paired Bone Marrow and Peripheral Blood: Implications for Monitoring Plasma Cell Disorders
    Janine M. Joseph, Joseph D. Tario, Han Yu +10
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  8. International patterns and incidence trends of leukemia in adolescents and young adults by subtype and sex: a population-based study
    Leiwen Fu, Weitao Su, Ke Liu +6
    BMC Public HealthPeer-reviewedCC BY-NC-ND 4.0OncologyCrossref
  9. Prognostic value of microRNA expression in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis
    Lőrinc Ulmann, Mahmoud Obeidat, Stefania Bunduc +7
    eBioMedicinePeer-reviewedCC BY-NC-ND 4.0Full textOncologyCrossrefDOAJPMC
  10. Roles of protein crotonylation in tumors: regulatory mechanisms and therapeutic potential
    Yaqian Liang, Qinyue Liu, Can Yang +4
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefDOAJEurope PMC
  11. Clinical Utility of lncRNAs in Urothelial Carcinoma of the Bladder: Diagnostics, Risk Stratification, and Treatment Guidance
    Janusz Ławiński, Beata Franczyk, Abdusalam Sagr +2
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0OncologyCrossref
  12. Novel Palladium(II) β-Diketonate Complexes: Synthesis, Dual Antimicrobial/Anticancer Activity, and Molecular Insights into DNA/Protein Interactions
    Marija Trifunović Stevanović, Nenad Joksimović, Jelena Petronijević +5
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0OncologyCrossref
  13. NEAT1 remodeling rewires the MYC degradation pathway
    Hagoon Jang, Bo Kyoung Suh, Feijie Zhang +6
    Nucleic Acids ResearchPeer-reviewedCC BY-NC 4.0Full textOncologyCrossref
  14. Seven Undescribed lindenane Sesquiterpenoid Dimers from the Aerial Parts of Sarcandra glabra and Their Inhibition of Nitric Oxide Production in LPS-Stimulated RAW 264.7 Cells
    Vu Quan Dang, Jae Sang Han, Yong Beom Cho +5
    ACS OmegaPeer-reviewedCC BY-NC-ND 4.0Full textOncologyCrossrefPMC
  15. MiR-22-3p shapes glioblastoma radiation resistance and downregulates the DNA demethylase tumor suppressor TET1
    Claire Loussouarn, Loris Roncali, Amandine Etcheverry +11
    Journal of Experimental and Clinical Cancer ResearchPeer-reviewedCC BYOncologyHAL
  16. How to prevent and manage PARP inhibitor-related hematological toxicities in prostate cancer?
    Ophelie Cassuto, Antonin Schmitt, Carole Helissey +6
    Bulletin du CancerPeer-reviewedCC BY-NC-ND 4.0Full text1 citedOncologyHAL
  17. Factors Associated With Recurrent Venous Thromboembolism During Extended Apixaban Therapy for Cancer-Associated Thrombosis
    Isabelle Mahé, Jean Chidiac, Marc Righini +12
    JACC: CardioOncologyPeer-reviewedCC BYFull textCardiovascular medicineOncologyHAL
  18. Surgical nodal staging in cervical cancer, a narrative review from the French cervical cancer guidelines group
    Yohann Dabi, Alejandra Martinez, Aymeline Lacorre +5
    Journal of Gynecology Obstetrics and Human ReproductionPeer-reviewedCC BY 4.0Full textEpidemiology & public healthOncologyObstetrics, gynaecology & paediatricsHAL
  19. Attractivité de la spécialité d’hématologie clinique en France : regards croisés des étudiants en médecine, d’internes, et d’hématologues en exercice
    Laurence Legros, Sylvain Choquet, Emmanuel Gyan +2
    Bulletin du CancerPeer-reviewedCC BY 4.0Full textOncologyHAL
  20. Indirect Calorimetry in Oncology: A Case-Based Clinical Tutorial
    Vivian V. Nguyen, Pamela Funk-Debleds, Kate Furness +6
    Clinical Nutrition ESPENPeer-reviewedCC BY 4.0Full textOncologyHAL
  21. Single-cell and spatial mapping reveals GCLC+ mesenchymal tumor cells linked with favorable outcomes in TNBC
    Nomeda Girnius, Tuulia Vallius, Wenqing Chen +14
    Communications BiologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  22. 53BP1 as a cofactor in the activation of the p53-family transcriptional program: A correlative multimodal microscopy approach
    Simone Pelicci, Laura Furia, Lorenzo Ciacci +4
    Science AdvancesPeer-reviewedCC BY-NCFull textOncologyCrossrefEurope PMC
  23. An in situ forming immunomodulatory hydrogel reinvigorates exhausted CD8 ⁺ T cells via preserving their mitochondrial fitness
    Yiming Qi, Jing Li, Ziyan Chen +11
    Science AdvancesPeer-reviewedCC BY-NCFull textOncologyCrossrefEurope PMC
  24. Extracorporeal photopheresis for the treatment of steroid-refractory immune related adverse events from immune checkpoint inhibitor therapy: a multi-center phase Ib/II clinical trial
    Roxane Riemer, Lukas M. Braun, Sophie Giesler +43
    Nature CommunicationsPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  25. Structural basis of bile acid lateral diffusion facilitated by the OSTα/β transporter
    Kang Xu, Bo-Rui Li, GaoXing Yu- Huang +8
    Nature CommunicationsPeer-reviewedCC BY-NC-ND 4.0Full textOncologyCrossref